EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Suppression of the HSP90-HIF1α pathway with SNX2112-encapsulated nano-micelles for effective triple-negative breast cancer photothermal combined photodynamic therapy

Zhiqi Zhang, Fangzheng Tian, Shiwei Lai, Xiaoxuan Xu, Mei Zhou, Zhenyu Hou, Siyu Li, Jianqiong Zhang, Xue Yang, Jinbing Xie, Shenghong Ju

Journal of Materials Chemistry B · 2025 · 13 (26) · 7753-7768

DOI: 10.1039/d5tb00071h ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2025. Verfasst von Zhiqi Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cultivation and Construction Site of the State Key Laboratory of Intelligent Imaging and Interventional Medicine, Department of Radiology, Zhongda Ho…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Photochemotherapy, HSP90 Heat-Shock Proteins, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enhanced photothermal and photodynamic therapy by supressing of the HSP90-HIF1α pathway is a promising strategy for the treatment of triple-negative breast cancer (TNBC) as it can accurately target tumor tissues and improve therapeutic efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsPhotochemotherapyHSP90 Heat-Shock ProteinsHypoxia-Inducible Factor 1, alpha SubunitPhotosensitizing AgentsAntineoplastic AgentsIndolesHumansFemaleAnimalsMiceChlorophyllidesReactive Oxygen SpeciesCell ProliferationCell Line, TumorMice, Inbred BALB CDrug Screening Assays, AntitumorPhotothermal TherapyMice, NudeNanoparticlesHeterocyclic Compounds, 4 or More Rings

Substanzen

HSP90 Heat-Shock ProteinsHypoxia-Inducible Factor 1, alpha SubunitSNX 2112ChlorophyllidesPhotosensitizing AgentsAntineoplastic AgentsHIF1A protein, humanReactive Oxygen SpeciesIndolesHeterocyclic Compounds, 4 or More Rings

Autor:innen und Institutionen

  • Cultivation and Construction Site of the State Key Laboratory of Intelligent Imaging and Interventional Medicine, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.…
  • Department of Microbiology and Immunology, Medical School, Southeast University, Nanjing, 210009, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Z., Tian, F., Lai, S., Xu, X., Zhou, M., Hou, Z., Li, S., Zhang, J., Yang, X., Xie, J., & Ju, S. (2025). Suppression of the HSP90-HIF1α pathway with SNX2112-encapsulated nano-micelles for effective triple-negative breast cancer photothermal combined photodynamic therapy. Journal of Materials Chemistry B, 13(26), 7753-7768. https://doi.org/10.1039/d5tb00071h

Vancouver

Zhang Z, Tian F, Lai S, Xu X, Zhou M, Hou Z, et al. Suppression of the HSP90-HIF1α pathway with SNX2112-encapsulated nano-micelles for effective triple-negative breast cancer photothermal combined photodynamic therapy. Journal of Materials Chemistry B. 2025;13(26):7753-7768. doi:10.1039/d5tb00071h

BibTeX
@article{Zhang2025,
  author = {Zhang, Zhiqi and Tian, Fangzheng and Lai, Shiwei and Xu, Xiaoxuan and Zhou, Mei and Hou, Zhenyu and Li, Siyu and Zhang, Jianqiong and Yang, Xue and Xie, Jinbing and Ju, Shenghong},
  title = {Suppression of the HSP90-HIF1α pathway with SNX2112-encapsulated nano-micelles for effective triple-negative breast cancer photothermal combined photodynamic therapy},
  journal = {Journal of Materials Chemistry B},
  year = {2025},
  volume = {13},
  number = {26},
  pages = {7753--7768},
  doi = {10.1039/d5tb00071h}
}
Kostenlos starten →